יחס חוב כולל להון עצמי Orgenesis Inc (ORGS)

This price chart illustrates the price action of Orgenesis Inc. (ORGS), where the debt-to-equity ratio stands at 0.00. Orgenesis Inc. (ORGS) develops software for cell therapy automation, the implementation of which into plant technical processes guarantees long-term payments. The business relies on cloud-based bioreactor management systems, creating high customer lock-in. However, the firm faces pressure from industry behemoths cutting prices, which is leading to a loss of market position.

This ratio measures the proportion of borrowed funds within the financing structure, determining the business's degree of dependence on creditors relative to its own equity. By analyzing the total debt-to-equity ratio, an investor will see the advantage of the asset-light model of Orgenesis Inc. (ORGS), where the shift away from costly plants in favor of mobile modules minimizes the debt load and strengthens the company's fundamental stability.